Holen Sie sich die Stockscreener-App
519.81
2.21%
11.23
Handel nachbörslich:
521.00
1.19
+0.23%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$508.58
Offen:
$514
24-Stunden-Volumen:
2.31M
Relative Volume:
1.24
Marktkapitalisierung:
$182.21B
Einnahmen:
$8.35B
Nettoeinkommen (Verlust:
$2.32B
KGV:
81.09
EPS:
6.41
Netto-Cashflow:
$1.30B
1W Leistung:
+7.41%
1M Leistung:
-9.40%
6M Leistung:
+7.31%
1J Leistung:
+32.70%
1-Tages-Spanne:
$511.95
$520.39
1-Wochen-Bereich:
$477.27
$520.39
52-Wochen-Spanne:
$364.17
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
519.81 | 182.21B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
228.08 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.80 | 45.90B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
221.29 | 32.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
225.80 | 16.82B | 2.88B | 499.60M | 321.60M | 6.74 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Is Intuitive Surgical Inc. (ISRG) the High-Valuation Stock to Buy According to Billionaires? - Insider Monkey
Restore Robotics Wins FDA Nod to Remanufacture Da Vinci Xi Instruments - MPO-mag
Is Intuitive Surgical Stock a Buy? - The Motley Fool
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Unlocking Intrinsic Value: Analysis of Intuitive Surgical Inc - GuruFocus.com
Laparoscopic Devices Market 2025 Growth, Business - openPR
Intuitive Surgical Inc (ISRG) Stock Price Up 3.17% on Mar 24 - GuruFocus.com
Q4 Earnings Review: Surgical Equipment & ConsumablesSpecialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG) - Yahoo Finance
Intuitive Surgical discloses pay for execs and median workers while urging votes against shareholder proposals - Medical Design & Outsourcing
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Intuitive Surgical is Known for Selling $1 Million Surgical Robots. But Here's How it Actually Makes Most of its Revenue. - MSN
Intuitive Surgical, Inc. (ISRG) Laps the Stock Market: Here's Why - MSN
Intuitive Surgical’s Biggest Moat Is NOT What You Think – Here’s Why It’s a Game-Changer! - Smartkarma
Medical Robotics Market is expected to reach US$ 61.33 billion - openPR
US Medical Robotics Market | Growth Trends, Innovations & - openPR
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.99%: What You Should Know - MSN
This Is What Whales Are Betting On Intuitive Surgical - Benzinga
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Baird Adjusts Price Target on Intuitive Surgical to $600 From $707, Keeps Outperform Rating - Marketscreener.com
(ISRG) Technical Data - Stock Traders Daily
Intuitive Surgical, Inc. (ISRG): The Best Biotech Stock to Buy According to Billionaires - Yahoo Finance
Is Intuitive Surgical, Inc. (ISRG) a Best Biotech Stock According to Billionaires? - MSN
Robotic Rehabilitation And Assistive Technologies Market - openPR
Will ISRG Stock Drop Continue After da Vinci 5 Recall? - Yahoo Finance
Robotic Surgery Program Designated as Total Program Observation Site - Lehigh Valley Health Network
BofA Defending Intuitive Surgical (ISRG) - StreetInsider.com
Erste Group cuts Intuitive Surgical stock rating to Hold - Investing.com
Erste Group Downgrades Intuitive Surgical (ISRG) to Hold (Friday pre-market) - StreetInsider.com
Intuitive Surgical’s SWOT analysis: robotic surgery leader faces tariff headwinds - Investing.com India
Intuitive Surgical price target lowered to $605 from $666 at Truist - TipRanks
Intuitive Surgical stock target cut to $605 by Truist Securities - Investing.com India
Truist Adjusts Price Target on Intuitive Surgical to $605 From $666, Maintains Buy Rating - Marketscreener.com
Intuitive Surgical Positioned for Growth Amidst Rising Adoption of Robotic Surgeries - TipRanks
Global Robotic Surgical Procedures Market to Reach $32.54B by 2034: Trends & Forecast - openPR
Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report? - MSN
15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey
Intuitive Surgical stock soars to all-time high of $608 - MSN
SEC Form DEF 14A filed by Intuitive Surgical Inc. - Quantisnow
Intuitive Surgical exec sells shares for $5.76 million - Investing.com India
Validea Detailed Fundamental AnalysisISRG - Nasdaq
Intuitive Surgical’s Strong Market Position and Technological Advancements Justify Buy Rating - TipRanks
Intuitive Surgical Breaks Out After Robotic Surgery Giant Crushes Quarterly Forecasts - MSN
Intuitive Surgical Inc (ISRG) Stock Price Down 3.73% on Mar 13 - GuruFocus.com
ISRG Stock Price Falls to 200-DMA: Should You Buy, Hold or Sell? - Yahoo Finance
FDA says Intuitive da Vinci 5 foot pedal recall is Class II - Mass Device
Some medtech stocks hit by tariff turmoil more than others - Mass Device
ISRG May 2nd Options Begin Trading - Nasdaq
Intuitive Surgical: Leading The Next-Generation Surgery Market (NASDAQ:ISRG) - Seeking Alpha
3 Unparalleled Growth Stocks You'll Regret Not Buying During the Nasdaq Stock Correction - The Motley Fool
Intuitive surgical EVP sells shares worth $6.37 million - Investing.com
Intuitive Surgical Executive Sells Shares Worth Over $6 Million - TradingView
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
0.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):